| 摘要 |
<p>Methods for treating treatment-naive as well as treatment-experienced patients having melanoma to increase the progression-free survival time involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g. , preferably pegylated interferon alfa-2b, as adjuvant therapy to definitive surgery are disclosed.</p> |
